Abstract:Abstract Background Cyclosporine A and Tacrolimus are immunosuppressive drugs that are commonly used in solid organ transplant and are characterized by a relatively narrow therapeutic index, potential drug interactions and significant intra- and inter-individual variability. Therapeutic drug monitoring is therefore beneficial for optimizing dosage regimens, preventing rejection of the graft and reducing toxicities in transplant recipients receiving immunosuppressive drug therapy. A commercial assay (RECIPE ClinMass LC-MS/MS Advanced kit) for simultaneous measurement of immunosuppressants in whole blood using LC-MS/MS methodology has been adapted for assay performance evaluation in our laboratory on the Agilent 1290 Infinity II liquid chromatograph coupled to an Agilent 6470 triple quadrupole mass spectrometer. Our study evaluated the analytical performance of Cyclosporine A and Tacrolimus on the RECIPE assay and compared it against our existing in-house LC-MS/MS assay. Methods The RECIPE ClinMass® LC-MS/MS Advanced Immunosuppressants assay kit consist of mobile phase solvents, precipitation reagents, stable isotopic labeled internal standards, solid phase extraction and analytical columns, lyohilized whole blood calibrators and quality controls. Drug analytes were extracted from whole blood using single-step protein precipitation followed by on-line solid phase extraction on the LC, eluted on isocratic chromatography and detected on positive ESI MS ionisation mode. The RECIPE assay run time is under 3 min. Performance validation parameters included within/total assay imprecision, linearity, recovery, limits of detection (LOD)/quantification (LOQ) and carry-over. Method correlation studies using fresh patient whole blood specimens (n = 212 Cyclosporine A; n = 120 Tacrolimus) were performed on existing in-house assay on Agilent 6460 LC-MS/MS and the RECIPE assay on Agilent 6470 LC-MS/MS systems. Results Within run and total imprecision for Cyclosporine A and Tacrolimus on the RECIPE assay were determined to be ≤4.4% and ≤7.5% on the Agilent 6470 LC-MS/MS. The assay demonstrated linearity across the analytical measurement range up to 1500 ug/L for Cyclosporine A and up to 55 ug/L for Tacrolimus. Analytical recoveries obtained for both drugs ranged between 93%–100%. The LODs were assessed to be 13.0 ug/L and 0.70 ug/L for Cyclosporine A and Tacrolimus respectively. LOQs were assessed to be 22.7 ug/L and 1.30 ug/L for Cyclosporine A and Tacrolimus respectively. Results of carry-over studies were insignificant. Participation in the CAP Immunosuppressive Drugs External Quality Assessment Survey showed good agreement with LC-MS/MS peers. Method correlation with in-house assay demonstrated good agreement: (1) Cyclosporine A: Passing Bablok regression RECIPE = 0.94 (In-house) + 17.2, Bland Altman mean bias of +2.0%, Spearman correlation coefficient of 0.985; (2) Tacrolimus: Passing Bablok regression of RECIPE = 1.03 (In-house) - 0.2, Bland Altman mean bias of -0.2%, Spearman correlation coefficient of 0.988 Conclusion The RECIPE ClinMass® LC-MS/MS Immunosuppressants assay performed within manufacturer’s specifications except for LOD/LOQs which were determined at higher concentrations. The assay is adaptable to contemporary LC-MS/MS systems and confer benefits from rapid turnaround time (<3 min), simplified specimen preparation procedures and ready prepared reagents. The advantages allow enhancements in workflow efficiency and ease of staff training in our laboratory and the assay is suitable for routine clinical use in high workload clinical laboratories.

Quantitative Measurement of Cyclosporin A in Blood by Time-of-Flight Mass Spectrometry

Measurement of ciclosporin in whole blood by HPLC

Quantification of cyclosporine A in peripheral blood mononuclear cells by liquid chromatography-electrospray mass spectrometry using a column-switching approach

Validation and evaluation of a newly developed time-resolved fluoroimmunoassay for cyclosporine quantitative analysis in human whole blood

Improved LC-MS/MS method for the simultaneous quantification of tacrolimus and cyclosporine A in human blood and application to therapeutic drug monitoring

Comparison between ultra-performance liquid chromatography with tandem mass spectrometry and a chemiluminescence immunoassay in the determination of cyclosporin A and tacrolimus levels in whole blood

Age Difference of Cyclosporin Dosage in Pediatric Patients

Label‐free optical detection of cyclosporine in biological fluids

Cyclosporine Monitoring by Fluorescence Polarization Immunoassay

Analysis of Cyclosporine A and Its Metabolites in Rat Urine and Feces by Liquid Chromatography–tandem Mass Spectrometry

Development and validation of a rapid HPLC‐MS/MS method for simultaneous determination of cyclosporine A and tacrolimus in whole blood for routine therapeutic drug monitoring in organ transplantation

B-310 High Through-put Online Solid Phase Extraction of Immunosuppressive Drugs From Whole Blood on Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) in a Tertiary Hospital Laboratory

Mass spectrometry quantitation of immunosuppressive drugs in clinical specimens using online solid-phase extraction and accurate-mass full scan-single ion monitoring

The measurement of whole blood pre-treatment cyclosporine A: metabolite ratios predicts the onset of renal dysfunction in recipients of allogeneic stem cell transplantation

Validation of an automated sample preparation module directly connected to LC-MS/MS (CLAM-LC-MS/MS system) and comparison with conventional immunoassays for quantitation of tacrolimus and cyclosporin A in a clinical setting

Quantitative, Highly Sensitive Liquid Chromatography–Tandem Mass Spectrometry Method for Detection of Synthetic Corticosteroids

A novel approach to therapeutic drug monitoring of Ciclosporin in pediatric renal transplant recipients using volumetric absorptive microsampling (VAMS) – Teaching old dog new tricks

Interlaboratory comparison study of immunosuppressant analysis using a fully automated LC-MS/MS system

Evaluation of a rapid micro-scale assay for tacrolimus by liquid chromatography-tandem mass spectrometry

Comparison of peak and trough level monitoring of cyclosporine treatment using two modern cyclosporine preparations

An evaluation of the cyclosporine parent‐compound‐specific whole blood TDx assay